Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
30.55
-1.70 (-5.27%)
May 21, 2026, 3:04 PM CST
SHE:301130 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 29.51 | 190.68 | 334.37 | 202.78 | 148.63 |
Short-Term Investments | - | - | - | 0.14 | 1.57 |
Trading Asset Securities | 206.95 | 84.93 | 213.15 | 413.17 | 65 |
Cash & Short-Term Investments | 236.46 | 275.6 | 547.52 | 616.08 | 215.2 |
Cash Growth | -14.21% | -49.66% | -11.13% | 186.28% | 22.20% |
Accounts Receivable | 55.73 | 57.43 | 49.14 | 56.78 | 58.44 |
Other Receivables | 2.35 | 4.01 | 6.43 | 3.23 | 3.36 |
Receivables | 58.08 | 61.44 | 55.57 | 60.01 | 61.8 |
Inventory | 28.19 | 27.97 | 27.36 | 20.7 | 26.58 |
Other Current Assets | 20.14 | 7.89 | 3.31 | 7.37 | 11.35 |
Total Current Assets | 342.86 | 372.91 | 633.76 | 704.17 | 314.93 |
Property, Plant & Equipment | 538.02 | 507.79 | 371.64 | 267.94 | 240.97 |
Long-Term Investments | 1 | - | - | - | - |
Goodwill | 30.57 | 30.57 | - | - | - |
Other Intangible Assets | 96.77 | 99.85 | 25.57 | 26.63 | 27.68 |
Long-Term Deferred Tax Assets | 10.02 | 7.92 | 7.59 | 7.85 | 7.9 |
Long-Term Deferred Charges | 0.86 | - | - | - | - |
Other Long-Term Assets | 41.47 | 43.54 | 28.63 | 10.42 | 3.13 |
Total Assets | 1,062 | 1,063 | 1,067 | 1,017 | 594.61 |
Accounts Payable | 48.84 | 42.43 | 28.45 | 6.12 | 6.24 |
Accrued Expenses | 2.37 | 17 | 14.46 | 20.88 | 21.34 |
Short-Term Debt | 11.53 | 10 | - | - | - |
Current Portion of Long-Term Debt | 0.08 | - | - | - | - |
Current Portion of Leases | - | 0.12 | 0.12 | - | - |
Finance Div. Other Current Liabilities | - | - | - | 1.5 | - |
Current Income Taxes Payable | 2.14 | 2.08 | 0.48 | - | 0.08 |
Current Unearned Revenue | 3.03 | 2.42 | 5.41 | 6.3 | 3.3 |
Other Current Liabilities | 20.43 | 5.06 | 4.78 | 3.94 | 3.73 |
Total Current Liabilities | 88.42 | 79.11 | 53.7 | 38.74 | 34.69 |
Long-Term Leases | - | 0.08 | 0.2 | - | - |
Long-Term Unearned Revenue | 33.6 | 37.12 | 29.61 | 32.7 | 35.78 |
Long-Term Deferred Tax Liabilities | 4.78 | 5.11 | 0.74 | 0.28 | - |
Other Long-Term Liabilities | - | - | 0.08 | - | - |
Total Liabilities | 126.8 | 121.41 | 84.33 | 71.71 | 70.47 |
Common Stock | 76.49 | 80.8 | 80.8 | 80.8 | 60.6 |
Additional Paid-In Capital | 363.57 | 461.37 | 461.37 | 461.37 | 90.64 |
Retained Earnings | 462.95 | 460.94 | 440.69 | 403.11 | 372.9 |
Treasury Stock | - | -100.01 | - | - | - |
Comprehensive Income & Other | 1.25 | 2.64 | - | - | - |
Total Common Equity | 904.27 | 905.75 | 982.86 | 945.29 | 524.14 |
Minority Interest | 30.51 | 35.42 | - | - | - |
Shareholders' Equity | 934.78 | 941.16 | 982.86 | 945.29 | 524.14 |
Total Liabilities & Equity | 1,062 | 1,063 | 1,067 | 1,017 | 594.61 |
Total Debt | 11.61 | 10.2 | 0.32 | - | - |
Net Cash (Debt) | 224.85 | 265.41 | 547.2 | 616.08 | 215.2 |
Net Cash Growth | -15.28% | -51.50% | -11.18% | 186.28% | 22.20% |
Net Cash Per Share | 2.94 | 3.41 | 6.77 | 7.96 | 3.55 |
Filing Date Shares Outstanding | 76.48 | 76.49 | 80.8 | 80.8 | 80.8 |
Total Common Shares Outstanding | 76.48 | 76.49 | 80.8 | 80.8 | 60.6 |
Working Capital | 254.44 | 293.8 | 580.06 | 665.44 | 280.24 |
Book Value Per Share | 11.82 | 11.84 | 12.16 | 11.70 | 8.65 |
Tangible Book Value | 776.93 | 775.33 | 957.29 | 918.66 | 496.46 |
Tangible Book Value Per Share | 10.16 | 10.14 | 11.85 | 11.37 | 8.19 |
Buildings | - | 396.8 | 306.44 | 276.72 | 265.7 |
Machinery | - | 121.2 | 108.6 | 104.63 | 102.37 |
Construction In Progress | - | 192.83 | 134.86 | 52.53 | 13.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.